Safety and tolerability of regadenoson in comparison with adenosine stress cardiovascular magnetic resonance: Data from a multicentre prospective registry

Severe Bradycardia and Asystole Following Regadenoson in Pharmacological Myocardial Perfusion Imaging

(2019) Laith A. Derbas et al.   JACC-Cardiovascular Imaging

Acute adverse events in cardiac MR imaging with gadolinium-based contrast agents: results from the European Society of Cardiovascular Radiology (ESCR) MRCT Registry in 72,839 patients

(2019) Johannes Uhlig et al.   EUROPEAN RADIOLOGY

Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease

(2019) Eike Nagel et al.   NEW ENGLAND JOURNAL OF MEDICINE

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

(2019) Juhani Knuuti et al.   EUROPEAN HEART JOURNAL

Gender-related differences in side-effects and hemodynamic response to regadenoson in patients undergoing SPECT myocardial perfusion imaging

(2019) Athanasios Katsikis et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Feasibility and accuracy of SPECT myocardial perfusion imaging in end-stage lung disease

(2019) Sanziana R. I. Schiopu et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Cardiac Magnetic Resonance Stress Perfusion Imaging for Evaluation of Patients With Chest Pain

(2019) Raymond Y. Kwong et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability

(2018) Juhani Knuuti et al.   EUROPEAN HEART JOURNAL

Intravenous Regadenoson with Aminophylline Reversal is Safe and Equivalent to Intravenous Adenosine Infusion for Fractional Flow Reserve Measurements

(2018) Justin A Edward et al.   CLINICAL CARDIOLOGY

Regadenoson use for stress myocardial perfusion imaging in advance chronic kidney disease and dialysis: Safe, effective, and efficient

(2017) Ankur Gupta et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Incidence of atrioventricular block with vasodilator stress SPECT: A meta-analysis

(2017) Efstathia Andrikopoulou et al.   JOURNAL OF NUCLEAR CARDIOLOGY

An assessment of the safety, hemodynamic response, and diagnostic accuracy of commonly used vasodilator stressors in patients with severe aortic stenosis

(2016) Nasir Hussain et al.   JOURNAL OF NUCLEAR CARDIOLOGY

ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers

(2016) Milena J. Henzlova et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Safety and tolerability of regadenoson for myocardial perfusion imaging – first Danish experience

(2016) Marianne Pape et al.   SCANDINAVIAN CARDIOVASCULAR JOURNAL

Pharmacological stress cardiovascular magnetic resonance: feasibility and safety in a large multicentre prospective registry

(2015) Jose V. Monmeneu Menadas et al.   European Heart Journal-Cardiovascular Imaging

Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials

(2014) Maria Octavia Rangel et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: A quantitative analysis from the ADVANCE MPI trials

(2014) John J. Mahmarian et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Safety and tolerability of regadenoson CMR

(2014) K.-L. Nguyen et al.   European Heart Journal-Cardiovascular Imaging

Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge

(2014) Rami Doukky et al.   International Journal of Chronic Obstructive Pulmonary Disease

A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease

(2012) Karthik Ananthasubramaniam et al.   JOURNAL OF NUCLEAR CARDIOLOGY

The safety and tolerability of regadenoson in patients with end-stage renal disease: The first prospective evaluation

(2012) Rami Doukky et al.   JOURNAL OF NUCLEAR CARDIOLOGY

A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease

(2012) Bruce M. Prenner et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Myocardial Perfusion: Near-automated Evaluation from Contrast-enhanced MR Images Obtained at Rest and during Vasodilator Stress

(2012) Giacomo Tarroni et al.   RADIOLOGY

Single-centre survey of the application of cardiovascular magnetic resonance in clinical routine

(2012) F. von Knobelsdorff-Brenkenhoff et al.   European Heart Journal-Cardiovascular Imaging

The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study

(2011) Edward V. R. DiBella et al.   INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING

Hemodynamic response, arrhythmic risk, and overall safety of Regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic obstructive pulmonary disease and bronchial asthma patients

(2011) Zehra Husain et al.   INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING

Selective adenosine agonists and myocardial perfusion imaging

(2011) Gilbert J. Zoghbi et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial

(2011) John P Greenwood et al.   LANCET

Prognostic Implications of Dipyridamole Cardiac MR Imaging: A Prospective Multicenter Registry

(2011) Vicente Bodi et al.   RADIOLOGY

Regadenoson: A New Myocardial Stress Agent

(2009) Wael Al Jaroudi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial

(2008) B LEAKER et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial)

(2008) G THOMAS et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging

(2008) Manuel D. Cerqueira et al.   JACC-Cardiovascular Imaging